Structure of the Francisella response regulator QseB receiver domain, and characterization of QseB inhibition by antibiofilm 2‐aminoimidazole‐based compounds. Issue 2 (16th August 2017)

• Record Type: Journal Article
• Authors: Milton, Morgan E.; Allen, C. Leigh; Feldmann, Erik A.; Bobay, Benjamin G.; Jung, David K.; Stephens, Matthew D.; Melander, Roberta J.; Theisen, Kelly E.; Zeng, Daina; Thompson, Richele J.; Melander, Christian; Cavanagh, John
• Is Part Of: Molecular microbiology. Volume 106:Issue 2(2017)
• Page Start: 223
• Page End: 235
• Publication Date: 2017-08-16
• Subjects: Molecular microbiology -- Periodicals; 572.829
• DOI: 10.1111/mmi.13759
• Languages: English
• ISSNs: 0950-382X

Abstract

Summary: With antibiotic resistance increasing at alarming rates, targets for new antimicrobial therapies must be identified. A particularly promising target is the bacterial two‐component system. Two‐component systems allow bacteria to detect, evaluate and protect themselves against changes in the environment, such as exposure to antibiotics and also to trigger production of virulence factors. Drugs that target the response regulator portion of two‐component systems represent a potent new approach so far unexploited. Here, we focus efforts on the highly virulent bacterium Francisella tularensis tularensis . Francisella contains only three response regulators, making it an ideal system to study. In this study, we initially present the structure of the N‐terminal domain of QseB, the response regulator responsible for biofilm formation. Subsequently, using binding assays, computational docking and cellular studies, we show that QseB interacts with2‐aminoimidazole based compounds that impede its function. This information will assist in tailoring compounds to act as adjuvants that will enhance the effect of antibiotics. Abstract : Targets for new antimicrobial therapies must be identified to combat rising antibiotic resistance worldwide. The 2‐aminoimidazole‐based adjuvant small molecules resensitize bacteria to conventional antibiotics. To elucidate one potential mechanism of action, we provide evidence that these compounds interact with a key transcriptional regulator from Francisella sp . The knowledge gained form these studies will inform future compound development.